Guest scientistMolecular Hematology, Sanquin Research, Amsterdam, The NetherlandsAmsterdam, Noord-Holland, Netherlands
OC 27.1 - Dominant negative effects of Gln50Arg mutation in the EGF-1 domain of factor IX causes severe Hemophilia B affecting factor IX replacement therapy
Sunday, June 23, 202414:45 – 15:00 ICT